Remove 2014 Remove Competition Remove Specialization
article thumbnail

Competition is on the horizon for costly narcolepsy treatments

pharmaphorum

But increased competition is on the horizon. In order to bring it to market, a special program called Risk Evaluation and Mitigation Strategy (REMS) had to be put in place, where only eligible patients could access the drug through a very strict process. Competition starts to heat up. Classic treatment options. About the author.

article thumbnail

Biogen’s $900 million settlement signals scrutiny on speaker fees

Pharmaceutical Technology

Between 2009 and 2014, the time period of Biogen’s alleged misconduct, the standard of care for MS involved the use of Biogen’s immunomodulatory drugs such as Avonex (Interferon beta-1a), Tecfidera (dimethyl fumarate), and Tysabri (natalizumab). More recently, Biogen has been facing competition from dimethyl fumarate generics.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

You get what you agree to, at least when it comes to the money under VPAS

pharmaphorum

The 2019 VPAS , just like its predecessor that was in place from 2014, has at its heart a payback mechanism. The ABPI has a special designation to represent all companies that sell branded medicines in any statutory consultation with the government. Predictable for government. Individual companies are lobbying, too.

article thumbnail

The Fastest Growing Companies in Boston Hiring For Sales

CloserIQ

Founded 2014. Founded 2014. BondLink is a fintech company specializing in the municipal bond market. Cybereason’s workplace culture is known to be fast-paced and competitive, with plenty of opportunities for learning. Founded 2014. Salsify offers competitive benefits and a flexible vacation plan.

Sales 76
article thumbnail

Five potential EU regulatory changes impacting the life sciences industry in 2023

European Pharmaceutical Review

Regulation of clinical trials Eight years following its adoption in 2014, the Clinical Trials Regulation 536/2014 (CTR) entered into application on 31 January 2022. Some of the current and anticipated proposals will not be adopted in 2023, or even before the end of tenure of the current European Commission in late 2024.

Medical 117
article thumbnail

Building CO2-neutral, defossilised supply chains for chemicals

European Pharmaceutical Review

16,17 However, care must be taken to ensure that chemicals from biomass are not produced in competition with food production and do not have a negative impact on the environment or natural habitats. His special interests are in the field of chemical policy and sustainable chemistry. Chem Commun 2014, 50, 9650‒9652.

article thumbnail

Virtual Reality Training For Medical Device Sales Reps With David Howe

Evolve Your Success

With VR simulations, sales reps can now hone their skills in lifelike scenarios, giving them a competitive edge in the field. Around 2014 and 2015, Oculus launched a kick-starter campaign and created the first mass-market VR headset. I landed this competitive scholarship at the National Cancer Institute at school.